戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ature collagen cross-links, pyridinoline and deoxypyridinoline.
2 o 55.7 +/- 25.5 nmol/mmol of creatinine) and deoxypyridinoline (8.4 +/- 7.1 nmol/mmol of creatinine t
3 ivalents (BCE)/mmol creatinine, p = 0.0014), deoxypyridinoline (8.42 +/- 2.8 versus 6.8 +/- 3.0 mmol/
4 h PYROXD1 myopathy showed elevated levels of deoxypyridinoline, a mature collagen crosslink, correlat
5 suring urinary excretion of pyridinoline and deoxypyridinoline and bone formation by measuring serum
6 d with low dietary protein decreased urinary deoxypyridinoline and increased serum insulin-like growt
7 were also correlated with lower excretion of deoxypyridinoline and were significant predictors of spi
8 Erythrocyte superoxide dismutase and urinary deoxypyridinoline are not useful biomarkers, but there w
9 d by measurement of urinary pyridinoline and deoxypyridinoline as a ratio to urinary creatinine.
10 omorphometry of the femur; increased urinary deoxypyridinolines, as determined by ELISA; and increase
11 nd osteocalcin) and bone resorption (urinary deoxypyridinoline) at baseline and 6 mo later.
12 e N-telopeptides of type I collagen and free deoxypyridinoline, both of which are markers of bone bre
13 erences between the groups were observed for deoxypyridinoline/creatinine values: intensive care pati
14                                       Plasma deoxypyridinoline cross-link and cross-linked carboxyter
15 o difference between groups for urinary free deoxypyridinoline cross-links relative to creatinine (fD
16 phosphatase (TRAP), and urinary excretion of deoxypyridinoline crosslinks and calcium.
17 of the serum calcium concentration and urine deoxypyridinoline crosslinks, an effect reversed by CT a
18 s time, mature CCLs such as pyridinoline and deoxypyridinoline developed in the murine infarcts but n
19 yridinium cross-links pyridinoline (PYD) and deoxypyridinoline (DPD) are established markers of bone
20 collagen cross-links, pyridinoline (PYD) and deoxypyridinoline (DPD), has been correlated to increase
21 on [urinary levels of pyridinoline (PYD) and deoxypyridinoline (DPD)] were also measured as well as p
22 one resorption (urine pyridinoline, PYD, and deoxypyridinoline, DPD) were elevated in the majority of
23 iochemical bone markers (pyridinoline [PYR], deoxypyridinoline [DPYR], procollagen type I carboxy-ter
24 er and osteoclast surface as well as urinary deoxypyridinoline excretion upon unloading.
25  turnover, as indicated by higher Ca(2+) and deoxypyridinoline excretion, phenomena exaggerated in th
26 noline excretion and 12% of the variation in deoxypyridinoline excretion.
27 g/cm(2)), free pyridinoline (fPYD), and free deoxypyridinoline (fDPD) were expressed relative to crea
28          The presence of pyridinoline (Pyr), deoxypyridinoline, glycosylated Pyr (Glc-Gal-Pyr), and C
29  and urinary excretion of hydroxyproline and deoxypyridinoline increased 2-fold to 3-fold during the
30                                     The free deoxypyridinoline level was increased in the amniotic fl
31 ion (P=0.04), and lower urinary excretion of deoxypyridinoline (P=0.02).
32 .014 mol/mol collagen), and the pyridinoline/deoxypyridinoline ratio was significantly higher (baseli
33 kaline phosphatase, osteocalcin, and urinary deoxypyridinoline, respectively.
34                         At 6 months, urinary deoxypyridinoline-to-creatinine ratio and 24-hour protei
35 ydroxypyridinium crosslinks pyridinoline and deoxypyridinoline, were selected for analysis in collage
36  of osteocalcin, IL-6, and urinary levels of deoxypyridinoline which, taken together, suggest develop